US Executive Officer Management Changes SEC — May 06, 2026

06-05-2026

At Leidos Holdings, Inc.'s Annual Meeting on May 1, 2026, stockholders elected all nine director nominees with strong majorities (ranging from 82.2M to 92.7M votes for), approved say-on-pay (88.9M for), ratified Deloitte & Touche LLP as auditors (97.3M for), and approved the 2026 Omnibus Incentive Plan (90.3M for) and 2026 Employee Stock Purchase Plan (93.5M for). While all proposals passed overwhelmingly, Robert S. Shapard received the highest opposition with 11.5M votes against compared to 1-4.7M for others. Broker non-votes were consistent at 10.5M across proposals requiring them.

• ·Director votes: Thomas A. Bell (92,671,357 for, 1,216,775 against); Gregory R. Dahlberg (91,801,057 for, 1,932,716 against); David G. Fubini (89,026,842 for, 4,737,376 against); Noel B. Geer (90,094,311 for, 3,675,875 against); Tina W. Jonas (91,579,107 for, 2,290,039 against); Harry M. J. Kraemer, Jr. (90,309,819 for, 3,499,434 against); Gary S. May (90,524,899 for, 3,239,893 against); Nancy A. Norton (91,823,309 for, 2,050,181 against); Patrick M. Shanahan (92,225,068 for, 1,538,565 against); Robert S. Shapard (82,238,171 for, 11,532,656 against)
• ·Say-on-pay: 88,904,849 for, 4,449,801 against, 764,873 abstentions
• ·2026 Omnibus Incentive Plan: 90,310,588 for, 3,322,318 against, 486,617 abstentions
• ·Proxy Statement filed March 19, 2026; Form S-8 filed May 1, 2026

06-05-2026

AEye, Inc. disclosed that Andrew S. Hughes, its General Counsel and Corporate Secretary, notified the company of his resignation effective May 15, 2026, to accept a position with an employer in an unrelated industry. The resignation did not arise from any disagreement with the company's operations, policies, or practices. No successor has been named in the filing.

• ·Resignation notification date: May 4, 2026
• ·Filing date: May 6, 2026
• ·Securities: Common Stock (LIDR) and Warrants (LIDRW) on Nasdaq

06-05-2026

On May 5, 2026, the Compensation Committee of Once Upon a Farm, PBC (OFRM) approved a revised compensation package for Lawrence Waldman, President and Chief Financial Officer, increasing his base salary to $450,000 per year (subject to annual review), annual cash bonus opportunity to 70% of base salary, and granting service-based restricted stock units with a grant date fair value of $1,000,000. The equity grant vests in full on the second anniversary of the effective date, subject to continued employment or certain termination events. No other changes to officer positions were reported.

• ·Compensation changes effective May 5, 2026
• ·Base salary subject to annual review by Compensation Committee
• ·RSU vesting accelerates due to certain termination events
• ·Filing signed by Chris Folena on May 6, 2026

06-05-2026

Anavex Life Sciences Corp. appointed Terrie Kellmeyer, PhD, former Senior Vice President of Clinical Development, as Interim Chief Executive Officer following the departure of President and CEO Christopher Missling, PhD, on April 30, 2026. Dr. Kellmeyer will advance the company's pipeline, including lead candidate oral blarcamesine for early Alzheimer’s disease, leveraging her extensive experience in regulatory submissions and clinical development. The company highlighted a strong cash balance with no long-term debt but disclosed a delay in filing its Form 10-Q for the quarter ended March 31, 2026, via a Form 12b-25 extension.

• ·CEO departure and board resignation requested on April 30, 2026
• ·Form 10-Q extension via Form 12b-25 for quarter ended March 31, 2026
• ·Planned conference call and webcast for second quarter 2026 financial results

06-05-2026

Seagate Technology Holdings plc announced the retirement of Michael R. Cannon, its Lead Independent Director, at the conclusion of his current term in October 2026, after 15 years on the Board since February 2011, including five years as Lead Independent Director and five as Board Chair. Cannon brings a 40-year history in the disk drive industry, with prior leadership roles at Maxtor, IBM, Control Data, and Boeing. CEO Dave Mosley highlighted Cannon's instrumental role in guiding Seagate through transformational changes and strategic growth.

• ·Cannon studied mechanical engineering at Michigan State University while working at General Motors.
• ·Cannon received Boeing Inventor of the Year award in 1983.
• ·Cannon led Maxtor Corporation's IPO in 1998.
• ·Seagate has over 45 years of innovations in mass-capacity data storage.

06-05-2026

Winmark Corporation announced that director Lawrence A. Barbetta will not stand for re-election at the April 2027 Annual Meeting due to term limits, after serving since 2012 on the Board and Audit Committee. The company appointed Stephanie S. Hoppe, VP of Omnichannel Marketing at Casey’s General Stores, to the Board and Compensation and Nominating Committees, bringing expertise in marketing and franchising. As of March 28, 2026, Winmark had 1,383 franchises in operation, over 2,800 available territories, and 79 awarded but not yet open.

• ·Lawrence A. Barbetta elected to Board in 2012.
• ·Annual Meeting of Shareholders scheduled for April 2027.
• ·Press release issued May 6, 2026.

06-05-2026

On May 6, 2026, the Board of Directors of Zion Oil & Gas, Inc. appointed Mr. Robert Dunn as Chairman of the Board, effective May 8, 2026, upon recommendation by the Nominating and Corporate Governance Committee. Mr. Dunn continues as Chief Executive Officer and will oversee routine operations of the Board, while Mr. John Brown remains as Executive Chairman to oversee strategic goals and vision, with no changes to their employment agreements. The changes follow internal company succession planning and involve no material plans, contracts, familial relationships, or related party transactions.

• ·Mr. Dunn has no other material plans, contracts, or arrangements with the Company modified by this appointment.
• ·No familial relationships or related party transactions requiring disclosure under Items 401(d) or 404(a) of Regulation S-K.

06-05-2026

Ryerson Holding Corporation adopted and filed its Fourth Amended and Restated Certificate of Incorporation, effective immediately upon filing on May 06, 2026, via unanimous board consent and stockholder approval. The amendment authorizes 107 million shares total (100 million common stock and 7 million preferred stock at $0.01 par value each), establishes a staggered three-class board structure, limits director removal to only for Cause, and restricts stockholder actions by written consent and special meeting calls after the Trigger Date when Platinum entities cease to hold majority voting power. Post-Trigger Date provisions also require 66 2/3% supermajority for amending Article V or bylaws.

• ·Originally incorporated as Rhombus Holding Corporation on July 16, 2007; prior amendments/restatements on December 31, 2007, January 4, 2010, and August 5, 2014.
• ·Registered office: Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware 19801, New Castle County.
• ·Trigger Date: first date Platinum entities and affiliates no longer beneficially own majority voting power.
• ·Cause for director removal: final felony conviction involving fraud/moral turpitude or willful misconduct materially injurious to the Corporation.

06-05-2026

Beauty Health Co (SKIN) filed a preliminary 8-K on May 6, 2026, under Item 5.02 for Director/Officer Departure/Election, disclosing ongoing negotiations for a separation agreement related to a director or officer. The company stated it will file an amendment within four business days after entering a definitive agreement. The report was signed by Michael Monahan, Chief Financial Officer of SkinHealth Systems Inc.

• ·Filing Type: 8-K
• ·Preliminary nature of the report due to ongoing negotiations

06-05-2026

Energy Recovery reported Q1 2026 revenue of $9.7 million, up 20% YoY from $8.1 million, with OEM channel up 65% to $6.6 million and megaproject revenue surging 911%, though aftermarket fell 32%. Gross margin plummeted 2750 bps to 27.8% due to $1.6 million restructuring charges on inventory from CO2 retail grocery wind down, resulting in operating loss of $14.9 million (improved 18.3% YoY but still deep red) and net loss widening to $12.3 million from $9.9 million. Leadership changes include CEO David Moon announcing retirement, CFO Mike Mancini resigning (Aidan Ryan as interim), alongside a new $25.0 million share repurchase authorization.

• ·Desalination segment revenue $8.9M (up from $7.8M YoY), Wastewater $0.6M (up from $0.3M), Emerging Technologies $0.2M (up from $0.001M but with $6.5M operating loss).
• ·Adjusted EBITDA loss improved to $7.1M from $8.7M YoY.
• ·Total assets decreased to $209.0M from $231.5M at year-end 2025.

06-05-2026

Orrstown Financial Services, Inc. elected Adam L. Metz, currently Senior Executive Vice President and Chief Operating Officer, as President, Chief Executive Officer, and Director of the Company and Orrstown Bank, effective June 1, 2026, upon the retirement of Thomas R. Quinn, Jr. from those positions. At the annual shareholder meeting on May 5, 2026, four Class A directors received an average of 95.81% support, the advisory Say-on-Pay vote for Named Executive Officers was approved by 94.91% of votes cast, and Crowe LLP's appointment as independent auditor for the fiscal year ending December 31, 2026, was ratified by 99.50% of votes cast.

• ·Adam L. Metz, age 54, joined in 2016; previously Senior Executive Vice President and Chief Operating Officer (since Feb 2025), Executive Vice President and Chief Revenue Officer (Feb 2019-Feb 2025), Executive Vice President and Chief Lending Officer (2016-Feb 2019), and Senior Vice President and Chief Lending Officer at Metro Bank (2011-2016).
• ·Mr. Metz to serve as Class B Director with term expiring at 2028 Annual Meeting of Shareholders.
• ·No family relationships or Item 404(a) disclosures for Mr. Metz.

06-05-2026

Mativ Holdings, Inc. held its 2026 Annual Meeting of Stockholders on April 30, 2026, where shareholders elected William M. Cook and Marco Levi as Class I directors with over 98% votes in favor each, ratified Deloitte & Touche LLP as the independent auditor with 98.5% approval, approved the advisory say-on-pay vote with 96% support, and approved Amendment No. 2 to the 2024 Equity and Incentive Plan increasing authorized common shares by 1,600,000 to a total of 6,700,000 shares with 95% approval. All proposals passed overwhelmingly with minimal opposition and abstentions. No significant dissent or failures noted.

• ·Proxy statement filed with SEC on March 17, 2026
• ·Annual Meeting held on April 30, 2026
• ·Form 8-K filed on May 6, 2026
• ·Common stock trades on New York Stock Exchange under symbol MATV

06-05-2026

Bright Mountain Media, Inc. reported the departure of Chief Financial Officer Ethan Rudin effective April 30, 2026, with severance pay equal to six months' base salary; CEO Matt Drinkwater will serve as interim principal financial and accounting officer until the next Form 10-Q filing. The company appointed Mr. Olgun (age 43) as the new CFO pursuant to an employment agreement dated May 1, 2026, with an annual base salary of $335,000, eligibility for an annual bonus up to 50% of base salary, and stock options for 1,000,000 shares at $0.004 per share vesting over four years. No other performance metrics or financial impacts were disclosed.

• ·Ethan Rudin's severance: six months' base salary per employment agreement.
• ·Mr. Olgun's prior roles: strategic finance consultant at Eventbrite, Inc. (Oct 2025 to appointment); CFO at Loop Media, Inc. (Mar 2022-Oct 2025); Director of Finance at United Pacific (Apr 2018-Mar 2022); started at Ernst & Young LLP (May 2004).
• ·Mr. Olgun credentials: CPA (2008), BA Business Management and Economics (UC Santa Cruz, 2004), MS Accountancy (University of Notre Dame, 2005).
• ·New CFO options vesting: first tranche on May 6, 2027, over four years per Stock Option Plan.
• ·Mr. Olgun covenants: non-competition/non-solicitation (1 year post-termination), non-disclosure (during and post-employment).
• ·Interim role for Matt Drinkwater until next Form 10-Q filing.

06-05-2026

On May 5, 2026, the independent board of ZeroStack Corp. granted 500,000 stock options each to CEO Daniel Reis-Faria and Executive Chairman Michael Heinrich, and 250,000 to CFO Dany Vaiman. The options have an exercise price of $5.10 per share, a 10-year term, and vest in 20% increments based on VWAP thresholds from $7.65 to $17.85, but remain unexercisable until seven days after closing the Share Exchange Agreement with Texas Blocker Corp. and are subject to shareholder approval at the annual meeting on or about July 13, 2026.

• ·Stock options unexercisable until seven days post-closing of Share Exchange Agreement
• ·Options subject to forfeiture without shareholder approval at July 13, 2026 meeting
• ·VWAP vesting thresholds: $7.65 (20%), $10.20 (20%), $12.75 (20%), $15.30 (20%), $17.85 (20%)

06-05-2026

Hamilton Insurance Group, Ltd. (NYSE: HG) announced on May 6, 2026, that Peter W. Wilson was elected to its Board of Directors at the Annual General Meeting of Shareholders. Wilson, with over three decades of insurance leadership experience including CEO of AXIS Insurance and senior roles at CNA Insurance Companies and AIG, was praised by Board Chair David A. Brown and CEO Pina Albo for his expertise in underwriting, operations, and governance. The appointment supports Hamilton's focus on cycle management, sustainable profitability, and strategic growth through its platforms: Hamilton Global Specialty, Hamilton Select, and Hamilton Re.

• ·Wilson has served on multiple boards including AXIS Specialty, CNA Europe, and QBE Insurance Group (Audit and Risk Committees).
• ·Wilson is a former President of the Professional Liability Underwriting Society (PLUS) and the PLUS Foundation.

06-05-2026

eHealth, Inc. reported Q1 2026 total revenue of $88.0 million, down 22% YoY from $113.1 million, reflecting lower Medicare approved members as part of a strategy to cut costs, though results exceeded expectations with Medicare gross margin expanding to 41% from 34% and constrained LTV of commissions improving across all Medicare products (MA +3%, Medicare Supplement +19%, Part D +78%). Operating costs and expenses decreased 16% to $90.9 million, with variable Medicare marketing spend down 45% YoY, but GAAP net loss of $4.7 million compared to $2.0 million net income in Q1 2025 due to $6.4 million restructuring charges, and adjusted EBITDA fell 28% to $9.0 million. The company launched its lifetime advisory model and final expense insurance offering, is on track for $90 million FY 2026 operating cost reductions, and reiterated full-year guidance.

• ·FY 2026 guidance: Total revenue $405.0M to $445.0M; GAAP net income $8.0M to $25.0M; Adjusted EBITDA $55.0M to $75.0M; Operating cash flow $(10.0)M to $12.0M; Positive net adjustment revenue $8M to $20M
• ·Commissions receivable balance of $1.0 billion as of March 31, 2026
• ·Cash, cash equivalents and short-term marketable securities of $110.8 million as of March 31, 2026
• ·Q1 2026 GAAP net loss margin of 5% compared to Q1 2025 GAAP net income margin of 2%
• ·Q1 2026 adjusted EBITDA margin of 10% compared to Q1 2025 adjusted EBITDA margin of 11%

06-05-2026

Flutter Entertainment plc announces a leadership transition at FanDuel, with Amy Howe departing as CEO and Christian Genetski, current President, assuming responsibility for leading the business. Dan Taylor, CEO of Flutter’s international division, takes on the newly created role of President, Flutter Entertainment, while continuing to lead international operations. The company highlights FanDuel's market leadership and releases Q1 FY2026 financial results separately, with FY2025 global revenue of $16,383m up 17% YoY and Q1 2026 revenue of $4,304m.

• ·Conference call scheduled for May 6, 2026 at 4:30 p.m. EDT (9:30 p.m. BST) to discuss Q1 FY2026 results; webcast at www.flutter.com/investors.
• ·Amy Howe joined FanDuel in 2021; Christian Genetski joined in 2015.

06-05-2026

Birchtech Corp. (NYSE American: BCHT; TSX: BCHT) announced the appointment of Michael Mioska, CPA, MBA, as Chief Financial Officer effective May 5, 2026, succeeding fractional CFO Fiona Fitzmaurice. Mr. Mioska brings over 20 years of experience in accounting, audit, financial reporting, and M&A advisory, including consulting for Birchtech since 2023. Management highlighted his familiarity with the company's operations to support growth in specialty activated carbon technologies for air and water treatment.

• ·Mr. Mioska has provided independent consulting services to Birchtech since 2023 and previously worked at a public accounting firm in Vancouver, BC since 2005.
• ·Birchtech recently uplisted to NYSE American.
• ·Investor Relations contact: Lucas A. Zimmerman, MZ Group – MZ North America.

06-05-2026

DocuSign, Inc. filed an 8-K on May 6, 2026 (AccNo: 0001261333-26-000050), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, reason for change, timing, or any quantitative metrics are disclosed.

06-05-2026

At the 2026 Annual Meeting of Shareholders on May 5, 2026, The Manitowoc Company, Inc. shareholders elected nine directors to serve one-year terms, approved the Amended and Restated 2025 Omnibus Incentive Plan authorizing 3,600,000 shares of common stock (including 1,800,000 additional shares), ratified Deloitte & Touche LLP as independent auditors for the year ending December 31, 2026, and approved executive compensation on an advisory basis. All proposals passed with majority support, though some directors received notable withheld votes (e.g., Kenneth W. Krueger with 2,532,836 withheld). No performance declines or flat metrics were reported.

• ·Nine directors elected with votes ranging from 20,545,782 (Kenneth W. Krueger) to 22,584,938 (Randy A. Wood) for, and withheld votes from 493,680 to 2,532,836.
• ·Advisory vote on executive compensation: 22,115,778 for, 872,325 against.
• ·Auditor ratification: 28,463,811 for, 114,706 against, 53,981 abstentions (no broker non-votes).
• ·Proxy Statement filed March 20, 2026; Plan effective May 5, 2026, terminates after tenth anniversary.

06-05-2026

At the 2026 Annual General Meeting on May 5, 2026, RenaissanceRe Holdings Ltd. shareholders elected four Class I directors—James L. Gibbons, Shyam Gidumal, Stephen C. Hooley, and Torsten Jeworrek—to serve until 2029, approved an advisory vote on named executive officer compensation, ratified the appointment of PricewaterhouseCoopers Ltd. as independent auditor, and approved the 2026 Long-Term Incentive Plan authorizing 1,250,000 common shares plus shares remaining from the prior plan. All proposals passed with a quorum of 40,162,748 shares (93.06% of 43,153,808 outstanding shares), though the LTIP faced notable opposition with 9,490,927 votes against compared to 28,846,544 for.

• ·Director election votes: James L. Gibbons (For: 34,398,054; Against: 4,005,559); Shyam Gidumal (For: 36,300,904; Against: 2,102,244); Stephen C. Hooley (For: 37,067,648; Against: 1,335,998); Torsten Jeworrek (For: 36,662,152; Against: 1,741,496).
• ·Exec comp advisory: For 37,045,795; Against 1,353,449.
• ·Auditor ratification: For 40,132,329; Against 2,946.

06-05-2026

Bionano Genomics, Inc. (Nasdaq: BNGO) announced Al Luderer, Ph.D., current Chairman of the Board, as interim President and Chief Executive Officer effective May 5, 2026, succeeding Erik Holmlin, PhD, who transitions to an advisor role. Chris Twomey will serve as Lead Independent Director, with the company expecting a seamless transition and no business disruption. Dr. Luderer brings over three decades of biotechnology experience, including prior CEO roles at Indi Molecular and BioTrove.

• ·Dr. Luderer served on Bionano's Board since November 2011 and as Chairman since June 2024.
• ·Previous experience includes President and CEO of BioTrove, CEO of Light Sciences, and President and COO of bioMérieux, Inc.
• ·Forward-looking statements highlight risks including going concern doubts within 12 months of the Annual Report on Form 10-K for year ended December 31, 2025.

06-05-2026

The Children’s Place, Inc. announced that Jared Shure will depart as Chief Administrative Officer, General Counsel, and Corporate Secretary effective June 1, 2026, with no disagreements on operations; Kenneth Li will succeed him in the General Counsel and Corporate Secretary roles for a smooth transition. At the 2026 Annual Meeting of Stockholders on May 6, 2026, shareholders approved the election of seven directors, ratification of BDO USA, P.C. as auditors, an increase of 1,200,000 shares under the 2011 Equity Incentive Plan, and advisory approval of executive compensation. The Board subsequently appointed committee chairs including Hussan Arshad (Audit), Douglas Edwards (Corporate Responsibility, Sustainability & Governance), and Muhammad Asif Seemab (Human Capital & Compensation).

• ·Director elections: For votes ranged 15,381,356 (Douglas Edwards) to 15,633,407 (Hussan Arshad); Against 205,658 to 429,671; Abstentions 31,812 to 76,707.
• ·Share plan increase: 15,270,578 for, 591,720 against, 9,730 abstentions.
• ·Say-on-pay: 15,243,731 for, 613,666 against, 14,631 abstentions.
• ·Auditor ratification: 17,612,248 for, 419,758 against, 83,519 abstentions (no broker non-votes).

06-05-2026

Carvana Co. filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, increasing authorized shares to a total of 3,175,000,000, consisting of 50,000,000 shares of Preferred Stock ($0.01 par), 2,500,000,000 shares of Class A Common Stock ($0.001 par), and 625,000,000 shares of Class B Common Stock ($0.001 par). Effective 9:30 a.m. ET on May 7, 2026, the company will execute a 1-for-5 forward stock split on both Class A and Class B Common Stock, with existing certificates automatically adjusting. The amendment was duly adopted by stockholders in accordance with Delaware law.

• ·Amends Article Four of the certificate originally filed April 27, 2017.
• ·Certificate executed on May 5, 2026.

06-05-2026

On April 30, 2026, Milestone Scientific Inc.'s Compensation Committee approved a stock option exchange program repricing 4.0 million underwater options (2.0 million each) held by CEO Eric Hines and SVP Jason Papes from $0.46-$0.50 to $0.31 per share, with accelerated vesting (25% initial, then two equal tranches) but no change in total shares. The Committee also approved grants of 11,202,513 performance-based RSUs (PRSUs) to officers including Hines (5,170,391 shares, 30%), Harcum (3,016,061, 17.5%), and Papes (3,016,061, 17.5%), tied to milestones over 2026-2029 such as organic sales >$11.0M-$15.0M, $50M market cap, and qualified acquisition >$10M revenue, from a 17,234,635 share pool, subject to shareholder approval of plan amendment. These measures aim to enhance retention and alignment without dilution or additional cash outlay.

• ·Repriced options granted in August 2025 and held by continuing employees with no prior repricing.
• ·PRSU performance period: January 1, 2026 to December 31, 2029.
• ·PRSUs vest upon milestone certification and continued service; no vesting for milestones achieved within 12 months of grant (except acquisition).
• ·Upon change in control, unvested PRSUs cancel except for prior certified milestones.
• ·Awards subject to stockholder approval of 2020 Plan amendment to increase share pool.

06-05-2026

TruGolf Holdings, Inc. appointed Steven Passey as Chief Financial Officer effective May 15, 2026, via an employment letter dated May 1, 2026. Mr. Passey, age 64, brings extensive experience including roles as CFO at Kinetic Energy Services, Catheter Precision, QSI Holdings, and Group Controller at Blackrock Neurotech. Compensation includes an initial annual base salary of $225,000 for the first three months, increasing to $250,000 thereafter, plus eligibility for equity grants and standard benefits.

• ·Mr. Passey holds a Bachelor of Science in Accounting from the University of Utah and is a Certified Public Accountant.
• ·No transactions in which Mr. Passey has an interest requiring disclosure under Item 404(a) of Regulation S-K.
• ·No family relationships between Mr. Passey and any director or executive officer of the Company.

06-05-2026

On April 30, 2026, Bimergen Energy Corporation amended employment agreements with Robert J. Brilon, updating his title to Co-Chief Executive Officer and Chief Financial Officer and increasing his base salary to $425,000 per year, and with Cole W. Johnson, updating his title to Co-Chief Executive Officer and President with the same salary increase. Both agreements include performance bonuses tied to milestones, a five-year term, and automatic one-year renewals unless terminated earlier. No departures or negative changes were reported.

• ·Amendments effective April 1, 2026
• ·Base salaries can be increased at the discretion of the Board of Directors
• ·Agreements qualified by Exhibits 10.1 (Brilon) and 10.2 (Johnson)

06-05-2026

General Mills (NYSE: GIS) promoted Dana McNabb to Chief Operating Officer, effective June 1, 2026, while also appointing her to the Board of Directors; she will report to Chairman and CEO Jeff Harmening and oversee all operating segments including International, North America Foodservice, Digital & Technology, Innovation, Supply Chain, and others. McNabb brings extensive experience, having served as Group President of North America Retail since 2024 and North America Pet since 2025, with prior roles in strategy, Europe & Australia, U.S. Cereal, and global marketing. The company reported fiscal 2025 net sales of $19 billion and share of non-consolidated joint venture net sales of $1 billion.

• ·McNabb started her General Mills career in Canada in 1999.
• ·Previous roles include Chief Strategy & Growth Officer; Group President, Europe & Australia; President, U.S. Cereal; Vice President, Global Marketing for CPW.
• ·Holds bachelor's degree in commerce from University of Ottawa and master's in business administration from London School of Business.

06-05-2026

On May 1, 2026, Hallador Energy Company's Board of Directors formed a new standing Risk Committee to oversee enterprise risk management, including strategic, operational, financial, market, and cybersecurity risks, appointing Daniel Hudson as Chair with an additional $25,000 annual cash retainer on top of the standard $200,000 for non-employee directors. Other members include Barbara Sugg, Brent Bilsland, Elliott Batson, and Todd Telesz. The Committee aims to enhance governance practices in support of long-term strategic objectives and potential financing activities.

• ·Risk Committee responsibilities include reviewing enterprise risk management policies, monitoring compliance, overseeing key risk identification and management, advising on strategic initiatives, and other duties delegated by the Board.
• ·Filing date: May 6, 2026; Event date: May 1, 2026.

06-05-2026

ModuLink Inc. (OTC: MDLK) appointed Dr. Henry Wah Shing Lam, aged 31 and founder of ASA Robotics Limited, as Chief Technology Officer effective May 1, 2026, to lead group-wide innovation, R&D, AI, robotics integration, and digital transformation following the recent acquisition of ASA Robotics. Dr. Lam's responsibilities include strategic technology partnerships and building a global engineering team, with CEO William Fu emphasizing alignment with long-term growth and acquisition integration. The appointment positions MDLK to leverage ASA Robotics' products like HORIZON patient transfer robot, LUNA fall-prevention system, and RAMP platform across its Modular Integrated Construction (MiC), Air-to-Water (A2W), and IoT portfolio.

• ·Dr. Lam holds a PhD in Biomedical Engineering and a first-class honours degree in Mechatronic Engineering from City University of Hong Kong.
• ·From 2020 to 2024, Dr. Lam served as a commission member of the Youth Development Commission of the HKSAR Government.
• ·Press release dated May 1, 2026; SEC 8-K filed May 6, 2026 for International Endeavors Corp (IDVV).

06-05-2026

Wiley (NYSE: WLY) announced the appointment of Jessica Kowalski as Executive Vice President and General Manager, Research, effective May 11, 2026, succeeding Jay Flynn who is leaving after shaping the Research business since 2021. Kowalski brings over two decades of experience from Microsoft, Amazon Web Services, and RELX, including AI, data, and publishing expertise, to advance Wiley's AI strategy. This follows the recent naming of Armughan Rafat as Chief AI and Data Services Officer.

• ·Jay Flynn joined Wiley in 2010 and assumed Research leadership in 2021
• ·Kowalski spent eleven years at RELX in senior positions at Elsevier and LexisNexis
• ·Wiley has over 200 years in the scholarly ecosystem

06-05-2026

United States Antimony Corporation (UAMY) announced that Senior Vice President and CFO Richard Isaak commenced a temporary personal leave of absence effective May 4, 2026, expected to last a minimum of two months and unrelated to company performance or financial reporting. The Board appointed Shawn Winkler, the company's prior financial consultant with over 20 years of experience including advising on $10B in M&A, as Interim CFO effective the same date. The company confirmed it remains on track for Q1 2026 financial results release on May 14, 2026.

• ·Shawn Winkler served as financial consultant for six months prior to appointment.
• ·Gary C. Evans has known Shawn Winkler for approximately twenty years.
• ·Q1 financial results cover period ending March 31, 2026.

06-05-2026

Actuate Therapeutics, Inc. (NASDAQ: ACTU) announced the immediate appointment of Martin Huber, MD, an oncology drug development veteran, as an Independent Director to strengthen leadership in advancing elraglusib for difficult-to-treat cancers. Dr. Huber brings experience from roles at Mersana Therapeutics, Xilio Therapeutics, and TESARO, contributing to approvals of multiple oncology drugs. However, the company discloses substantial doubt about its ability to continue as a going concern, requiring additional capital beyond Q2 FY2026 to fund operations.

• ·Mersana Therapeutics acquired by Day One Pharmaceuticals in January 2026.
• ·Annual Report on Form 10-K for year ended December 31, 2025, filed with SEC on March 26, 2026.
• ·Investor contact: mmoyer@lifesciadvisors.com; Media contact: (858) 717-2310.

06-05-2026

Regenerex Pharma, Inc. placed CFO Kenneth Perry on administrative suspension with pay effective March 31, 2026, and terminated his employment for Cause on May 2, 2026, following a board review determining a material breach of his employment agreement. The board appointed Don E. Ray as Interim CFO effective April 1, 2026, for an initial 90-day term. This sudden leadership change raises concerns about internal controls and financial oversight.

• ·Perry's suspension effective March 31, 2026.
• ·Board determination of Cause on April 27, 2026, by independent directors following Governance and Nominating Committee review.
• ·Termination notice delivered May 2, 2026.